3.67
前日終値:
$3.65
開ける:
$3.62
24時間の取引高:
38,476
Relative Volume:
0.28
時価総額:
$12.33M
収益:
$36.12M
当期純損益:
$-232.49M
株価収益率:
-0.2064
EPS:
-17.78
ネットキャッシュフロー:
$-126.87M
1週間 パフォーマンス:
-1.34%
1か月 パフォーマンス:
-11.57%
6か月 パフォーマンス:
-76.07%
1年 パフォーマンス:
-93.71%
Bionano Genomics Inc Stock (BNGO) Company Profile
名前
Bionano Genomics Inc
セクター
電話
(858) 888-7600
住所
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
BNGO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BNGO
Bionano Genomics Inc
|
3.67 | 12.51M | 36.12M | -232.49M | -126.87M | -17.78 |
![]()
ISRG
Intuitive Surgical Inc
|
552.34 | 193.38B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
172.59 | 49.12B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
85.94 | 42.79B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
244.79 | 35.61B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
BAX
Baxter International Inc
|
30.50 | 15.46B | 11.89B | -560.00M | 191.00M | -1.10 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-11-15 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
2024-09-10 | ダウングレード | BTIG Research | Buy → Neutral |
2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
2022-12-12 | 再開されました | BTIG Research | Buy |
2022-07-18 | 再開されました | Oppenheimer | Outperform |
2021-06-16 | 開始されました | BTIG Research | Buy |
2020-09-24 | 開始されました | Ladenburg Thalmann | Buy |
2020-04-08 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Bionano Genomics Inc (BNGO) 最新ニュース
How To Trade (BNGO) - news.stocktradersdaily.com
Bionano Genomics stock rises on Q1 revenue beat - MSN
Bionano Genomics, Inc. (NASDAQ:BNGO) Given Average Rating of “Hold” by Analysts - Defense World
Bionano Genomics (NASDAQ:BNGO) Stock Rating Upgraded by Wall Street Zen - Defense World
Maxim Group Upgrades Bionano Genomics (NASDAQ:BNGO) to Buy - Defense World
Maxim Group Upgrades Bionano Genomics (BMV:BNGO) - Nasdaq
Maxim Group Upgrades Bionano Genomics (LSE:0A4K) - Nasdaq
Maxim Group Upgrades Bionano Genomics (BNGO) - Nasdaq
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upg - GuruFocus
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upgrade | BNGO Stock News - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brig - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brighten | BNGO Stock News - GuruFocus
Maxim Upgrades Bionano Genomics to Buy From Hold, $8 Price Target - marketscreener.com
Bionano (BNGO) Achieves Milestone with New CPT Code for Genetic - GuruFocus
(BNGO) Long Term Investment Analysis - news.stocktradersdaily.com
Bionano Laboratories Announces a Second Category I CPT Code - GlobeNewswire
Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders - Yahoo Finance
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2025 Earnings Call Transcript - Insider Monkey
Biggest stock movers Thursday: UNH, CSCO, NTES, FL, BABA, and more - MSN
Biggest stock movers Thursday: CSCO, FL, BABA, BNGO, and more - MSN
Biggest stock movers Thursday: CSCO, BNGO, and more - MSN
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Na - GuruFocus
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Q1 2025 Earnings Call Transcript - MarketBeat
BNGO Stocks Projected to Install Up to 20 New OGM Systems in 202 - GuruFocus
Bionano Genomics Retail Mood Turns ‘Extremely Bearish’ Amid Revenue Guidance Shortfall - Asianet Newsable
Bionano Genomics (BNGO) Refocuses Strategy Amid Revenue Dip - GuruFocus
Bionano outlines $26M–$30M 2025 revenue target as strategic pivot drives higher gross margin - MSN
Earnings call transcript: Bionano Genomics Q1 2025 sees revenue drop, stock surges - Investing.com
Bionano Genomics (BNGO) Sees Strategic Shift Boost in Q1 2025 | - GuruFocus
Bionano Genomics Q1 2025 Earnings: Revenue Beats Estimates at $6 - GuruFocus
Bionano Genomics stock rises on Q1 revenue beat (BNGO:NASDAQ) - Seeking Alpha
BNGO Stocks Projected to Install Up to 20 New OGM Systems in 2025 | BNGO Stock News - GuruFocus
Bionano Genomics (BNGO) Forecasts Lower Q2 Revenue Than Expected - GuruFocus
Bionano Genomics (BNGO) Forecasts Lower Q2 Revenue Than Expected | BNGO Stock News - GuruFocus
Bionano Genomics Q1 2025 Financial Results - TradingView
A Glimpse of Bionano Genomics's Earnings Potential - Nasdaq
Bionano Genomics (BNGO) Boosts Cancer Diagnostics with New Study - GuruFocus
Bionano Genomics (BNGO) Boosts Cancer Diagnostics with New Study Findings | BNGO Stock News - GuruFocus
Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies - The Manila Times
Bionano Laboratories Announces Publication of the Largest - GlobeNewswire
Bionano Genomics (BNGO) Projected to Post Earnings on Wednesday - The AM Reporter
Bionano Genomics (BNGO) to Release Quarterly Earnings on Wednesday - Defense World
When (BNGO) Moves Investors should Listen - news.stocktradersdaily.com
Renaissance Technologies LLC Takes Position in Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 - The Manila Times
Geode Capital Management LLC Acquires 114,822 Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Bionano Genomics Inc (BNGO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):